WHO donates Kala-Azar drugs to Health Cluster partners in South Sudan
The World Health Organization (WHO) , with FCDO funding, has donated Kala-Azar medicines to Health Cluster partners working in the Upper Nile and Equatoria regions.
Among the recipient partners, include the IMC, Medair, SDS, and the International Committee of the Red Cross and the drugs will go a long way towards eradicating the endemic disease in the country.
Data shown by the World Health Organization indicate that Kala-Azar remains one of the deadliest tropical diseases afflicting the local population in some parts of the country, namely Upper Nile, Jonglei, Unity and Equatoria.
According to the WHO, In September 2009, an outbreak of kala-azar started with increased incidence in Upper Nile and Northern Jonglei. The outbreak continued for five consecutive years, peaking in 2011 and recording more than 11 952 cases; it spread to other areas and affected more people, mainly children aged below 17 years.
South Sudan also experienced another outbreak in 2014, following the conflict in December 2013, where over 7892 cases were reported. With the same interventions put in place, the numbers of cases gradually declined from 7892 in 2014, 3251 in 2015, 4601 in 2016, 4069 in 2017 and 1990 in 2018. However, the disease trends are unpredictable.